Unglycosylated human interleukin-2 polypeptides
US5700913A · kind A · utility
16Cited by
9References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 28, 1994 |
| Grant date | Dec 23, 1997 |
| Priority date | — |
| Expiry date | Oct 28, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/55
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Recombinant human Interleukin-2 (IL-2) polypeptides are provided. The polypeptides are produced by expression of suitable nucleic acid molecules in transformed host cells such as E. coli.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.